Skip to content
Clinical Trials – home
DenmarkBack to Denmark

Clinical trials in Hillerød – page 93

1 196 clinical trials in Hillerød, Denmark across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Hillerød at a glance
1 196
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

1 196 trials in Hillerød

Open in trial search

Atrial fibrillation+2

Not recruiting

Study on Dabigatran, Apixaban, Rivaroxaban, and Edoxaban for Patients with Atrial Fibrillation, Deep Vein Thrombosis, or Pulmonary Embolism

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Gentofte Hospital

Osteoarthritis

Not recruiting

Study on Spinal vs. General Anaesthesia with Ropivacaine Hydrochloride for Osteoarthritis Patients Undergoing Hip and Knee Replacement

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Chloride
  • Sponsor:Hvidovre Hospital

Plasma cell myeloma

Not recruiting

Study to Compare Mezigdomide, Carfilzomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Carfilzomib
  • Sponsor:Celgene Corp.

Cardiac failure

Not recruiting

Comparing Spironolactone and Eplerenone for Patients with Heart Failure and Reduced Ejection Fraction

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Eplerenone
  • Sponsor:Region Hovedstaden

Study on Colchicine for Reducing Inflammation in Patients with Type 1 Diabetes

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Colchicine
  • Sponsor:Gentofte Hospital

Pulmonary embolism+2

Not recruiting

Study on Tinzaparin and Dalteparin for Patients with Venous Thromboembolism

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Dalteparin Sodium
  • Sponsor:Region Hovedstaden

Study of LY3819469 for Adults with High Lipoprotein(a) Levels

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:LY3819469 sodium
  • Sponsor:Eli Lilly & Co.

Study for Patients with Advanced Malignancies: Continued Treatment with Parsaclisib Alone or with Itacitinib, Ruxolitinib, Ibrutinib, or Tafasitamab

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Ibrutinib
  • Sponsor:Incyte Corp.

Perineal injury

Not recruiting

Study on Amoxicillin and Clavulanic Acid to Prevent Infection in Women with Obstetric Perineal Tear

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Amoxicillin
  • Sponsor:Region Hovedstaden

Follicular lymphoma+2

Not recruiting

Study of Mosunetuzumab for Patients with Early Relapse of Follicular Lymphoma

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Mosunetuzumab
  • Sponsor:Oslo University Hospital HF

Neoplasm

Not recruiting

Study of Pembrolizumab for Patients with Advanced Solid Tumors

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Merck Sharp & Dohme LLC

Study on MK-7684A and Docetaxel for Treating Metastatic Non-Small Cell Lung Cancer in Patients After Platinum Chemotherapy and Immunotherapy

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:Merck Sharp & Dohme LLC

Other cities in Denmark

The busiest research cities in the country

All 45 cities in Denmark

Clinical research in Hillerød

What the registry says about research in the country

01 Gastroenterology Research

Ongoing clinical trials focusing on inflammatory bowel diseases, particularly investigating new treatments for Crohn's Disease and Ulcerative Colitis. Studies are evaluating the effectiveness of oral medications and biological therapies for managing moderate to severe cases.

  • Treatment optimization studies
  • Long-term disease management
  • Bowel wall healing assessment

Advanced therapeutic approaches aim to improve patient outcomes and quality of life.

02 Metabolic Disorders

Research initiatives targeting obesity and type 2 diabetes, with trials exploring innovative treatments combining medication with lifestyle modifications. Special focus on investigating new therapies for patients with concurrent weight management needs.

  • Weight management protocols
  • Diabetes control strategies
  • Combined therapeutic approaches

Studies aim to improve metabolic health outcomes through targeted interventions.

03 Cardiovascular Studies

Innovative research focusing on heart failure prevention and management of atrial fibrillation. Clinical trials are evaluating new medications and therapeutic combinations to reduce cardiovascular risks and improve patient outcomes.

  • Preventive cardiology
  • Stroke prevention
  • Cardiac treatment optimization

Advanced approaches in cardiovascular disease management and prevention.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.